MRSN - Mersana Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Annual

Balance Sheet

All numbers in thousands
Breakdown
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Assets
Current Assets
Cash
Cash And Cash Equivalents
59,634
26,591
100,297
11,534
Short Term Investments
10,497
88,143
-
-
Total Cash
70,131
114,734
100,297
11,534
Net Receivables
459
784
1,051
640
Inventory
-
-
-
-
Other Current Assets
-
0
0
0
Total Current Assets
70,131
117,543
102,173
12,754
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
9,055
7,459
6,695
4,841
Accumulated Depreciation
-6,361
-5,140
-4,212
-3,557
Net property, plant and equipment
2,694
2,319
2,483
1,284
Equity and other investments
0
10,482
-
-
Goodwill
-
-
-
-
Intangible Assets
-
-
-
-
Other long-term assets
1,503
371
431
371
Total non-current assets
8,371
13,172
2,914
1,655
Total Assets
78,502
130,715
105,087
14,409
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Total Revenue
-
-
-
-
Accounts Payable
10,727
3,070
2,068
2,025
Taxes payable
-
-
-
-
Accrued liabilities
12,375
3,903
1,152
341
Deferred revenues
46,196
21,635
22,731
7,054
Other Current Liabilities
-
0
0
0
Total Current Liabilities
69,425
31,881
28,386
10,735
Non-current liabilities
Long Term Debt
-
-
-
-
Deferred taxes liabilities
-
-
-
-
Deferred revenues
0
28,773
37,571
10,070
Other long-term liabilities
-
0
0
0
Total non-current liabilities
282
28,840
132,320
46,366
Total Liabilities
69,707
60,721
160,706
57,101
Stockholders' Equity
Common Stock
3
3
1
1
Retained Earnings
-164,166
-97,878
-59,171
-45,471
Accumulated other comprehensive income
-8
-149
-
-
Total stockholders' equity
8,795
69,994
-55,619
-42,692
Total liabilities and stockholders' equity
78,502
130,715
105,087
14,409